Centricity High Acuity Anesthesia System Recalled: Health Canada

Health Canada has classified a Type II recall for GE Healthcare’s Centricity High Acuity (CHA) Anesthesia system after the manufacturer identified two separate display and printout errors that could affect how patient orders are recorded and presented to clinical staff. The recall notice, identified under reference number RA-82614, was issued on September 3, 2026, and published by Health Canada on September 10, 2026.

The affected system is used in general hospital settings to manage and display anesthesia-related orders during high-acuity patient care. Because the CHA platform feeds directly into printed reports and on-screen order summaries relied on by clinicians, any inaccuracy in that data carries the potential to affect treatment decisions.

What Products Are Being Recalled?

The recall covers the ‘Centricity High Acuity Anesthesia’ system, model or catalogue number 5854437-019. Two specific units have been listed with distinct lot or serial numbers: CHAA-21020950 and JGHCHAA. The product is manufactured and distributed by GE Healthcare IITS USA Corp, doing business as GE Healthcare, based in Chicago, Illinois.

What Went Wrong?

According to Health Canada, GE Healthcare became aware of two potential issues tied to certain CHA systems. The first, described as ‘Safety issue #1,’ involves the order and recording summary component used within CHA application displays and printed reports. The second, ‘Safety issue #2,’ relates to the flexible order summary printout component of the system.

In practical terms, these are performance-related defects in how the software compiles and outputs order information rather than a hardware failure. If order or recording summaries do not display or print accurately, hospital staff working in high-acuity anesthesia settings could be working from incomplete or incorrect information, raising the risk of documentation or order-tracking errors during patient care.

Who Is Affected?

This is a health product recall directed at the healthcare sector rather than individual consumers. Hospitals, anesthesia departments, and clinical facilities that operate Centricity High Acuity systems with the listed model and lot numbers are the intended audience. The recall was published under Health Canada’s medical devices category, specifically covering general hospital and personal use equipment.

Because the issue concerns a clinical software and reporting function rather than a consumer-facing product sold at retail, patients themselves are not expected to take direct action, though facilities using the affected systems should review their equipment against the listed identifiers.

What Should You Do?

Health Canada’s guidance for this recall is limited to institutional users. Facilities operating the affected Centricity High Acuity Anesthesia system, model 5854437-019, with lot or serial numbers CHAA-21020950 or JGHCHAA, are advised to contact GE Healthcare directly if they require additional information about the safety issues or next steps.

Healthcare administrators should confirm whether their systems match the affected model and serial identifiers, and should route any questions about interim safeguards, software updates, or replacement components through GE Healthcare’s official channels rather than relying solely on the printed or displayed order summaries until confirmation is received.

Regulatory Response

Health Canada has classified this action as a Type II recall, a designation the agency uses for situations where use of, or exposure to, a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious harm is remote. The recall falls under the broader category of ‘Health products – Medical devices – General hospital and personal use.’

The notice was published by Health Canada, with the manufacturer listed as GE Healthcare IITS USA Corp, also doing business as GE Healthcare, of 500 W. Monroe Street, Chicago, Illinois. Anyone seeking further detail on the two identified safety issues is directed to contact the manufacturer, as Health Canada’s public notice does not include a consumer refund or replacement process, reflecting the recall’s institutional, rather than retail, scope.

Health Canada continues to monitor medical device recalls of this kind and encourages healthcare providers to report any related concerns through its official reporting channels.